Current Atherosclerosis Reports, published by CURRENT MEDICINE GROUP, is a leading scientific journal in the field of Cardiology and Cardiovascular Medicine, boasting an impressive Q1 ranking in its category as of 2023. This esteemed journal, with an ISSN of 1523-3804 and an E-ISSN of 1534-6242, has been a cornerstone of cardiovascular research since its inception in 1999, continuing to publish cutting-edge studies through 2024. With unparalleled insights into the mechanisms, prevention, and treatment of atherosclerosis, it serves as an essential resource for researchers, healthcare professionals, and students alike. Although not an open-access journal, it is highly regarded within the academic community, highlighted by its Scopus rank of #54 out of 387 in its field, placing it in the 86th percentile. The journal's commitment to advancing knowledge in cardiovascular health underscores its integral role in guiding clinical practices and influencing future research directions.

Molecular Therapy Nucleic Acids is a premier open-access journal published by CELL PRESS, dedicated to advancing the field of molecular medicine through the innovative application of nucleic acid-based therapies. Since its inception in 2012, this journal has become an essential resource for researchers and professionals in drug discovery and molecular medicine, reflected in its status as a Q1 journal in both categories for 2023. With a notable impact factor and high rankings in Scopus, including #8 out of 157 in Drug Discovery and #16 out of 178 in Molecular Medicine, it serves to disseminate groundbreaking research and foster collaborations among scientists worldwide. The journal's comprehensive scope encompasses a wide variety of topics, including gene therapy, RNA interference, and CRISPR technology, ensuring that it remains at the forefront of scientific excellence. With open access availability, Molecular Therapy Nucleic Acids actively promotes the widespread dissemination of knowledge, making its crucial insights accessible to students, researchers, and industry professionals alike.

Chemistry and Physics of Lipids is a prestigious and influential journal dedicated to advancing the understanding of lipid chemistry and biophysics. Published by Elsevier Ireland Ltd, it serves as a vital resource for researchers and professionals in the fields of biochemistry, cell biology, and molecular biology. The journal has a strong standing within the academic community, as reflected in its 2023 Scopus rankings, where it places in the 82nd percentile for organic chemistry and maintains significant positions in various biochemistry subfields. Spanning from 1966 to 2024, it fosters a comprehensive discourse on lipid-related research and innovation. As a renowned publication in the Q2 and Q3 quartiles across several categories, it supports the dissemination of high-quality research aimed at elucidating lipid functions and their implications in health and disease. Researchers and students alike will find this journal invaluable for staying updated with the latest developments and trends in lipid research.

Welcome to BIOCHIMIE, a prestigious journal dedicated to advancing the field of biochemistry and related areas of medicine. Published by Elsevier France - Editions Scientifiques Medicales Elsevier, this journal has been a cornerstone of scientific communication since its inception in 1971 and will continue to contribute essential research until 2024. With an impressive impact factor and categorized in Q2 for Biochemistry and Q1 for Miscellaneous Medicine, BIOCHIMIE ranks among the top quartiles in its fields, underscoring its significance and influence in the scientific community. Targeting a wide audience of researchers, professionals, and students, the journal publishes high-quality articles that explore innovative research and developments in biochemistry, genetics, and molecular biology, reflected in its Scopus ranking of 136 out of 438 in the biochemistry category. Despite its traditional publication format, the journal remains committed to promoting impactful research that drives the future of biochemistry and molecular medicine, ensuring that readers have access to critical insights that foster advancements in health and science.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

PHYCOLOGICAL RESEARCH is a leading journal in the field of aquatic and plant sciences, published by Wiley, recognized for its commitment to advancing knowledge in the study of algae and their ecological significance. With a diverse scope encompassing ecological interactions, evolutionary behaviors, and physiological processes, PHYCOLOGICAL RESEARCH aims to provide a platform for researchers to disseminate innovative findings and insights pertinent to both agricultural and biological sciences. The journal's impressive rankings—placing it in the 74th percentile within Agricultural and Biological Sciences (miscellaneous) and holding a Q2 category in key fields—underscore its impact and importance in academia. Despite not being open access, the journal ensures broad distribution and visibility through its dedicated readership. Since its inception in 1995, PHYCOLOGICAL RESEARCH has continuously evolved, shaping and influencing the direction of research in phycology and related disciplines, making it an essential resource for students, professionals, and researchers alike.

PROSTAGLANDINS & OTHER LIPID MEDIATORS, published by Elsevier Science Inc, is a leading journal dedicated to the advancements in the field of lipid mediators, with a specific focus on prostaglandins and other bioactive lipids. This journal, indexed under ISSN 1098-8823 and E-ISSN 2212-196X, serves as a crucial platform for researchers and professionals to disseminate significant findings that span multiple disciplines, including Biochemistry, Cell Biology, Pharmacology, and Physiology. In the 2023 category quartiles, it has achieved commendable positions such as Q2 in Biochemistry and Q2 in Physiology, underscoring its importance and influence in these domains. Although it is not an open-access journal, it provides robust access options, enhancing the visibility of vital research. With its establishment in 1996, the journal continues its commitment to fostering innovative research until 2024, making it an essential resource for those involved in the dynamic realms of lipid biology and medical research.

BIOLOGICHESKIE MEMBRANY is a critical journal in the field of Cell Biology and Molecular Biology, published by MEZHDUNARODNAYA KNIGA in the Russian Federation. With an ISSN of 0233-4755, this journal has been serving the academic community since 1996 and continues to publish cutting-edge research that advances our understanding of biological membranes and their functions. Despite being classified in Q4 quartiles for both Cell and Molecular Biology in the 2023 category rankings, the journal presents a unique platform for emerging research within these pivotal areas. Researchers, professionals, and students alike will find valuable insights in its pages as it seeks to foster a collaborative environment that encourages knowledge sharing. Although currently not available as an open-access journal, it remains an essential resource for those looking to deepen their knowledge and contribute to ongoing discussions in the biological sciences. The journal’s commitment to publishing quality research is underscored by its continuous coverage until 2024, making it a sustained reference in the field.

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

Nature Metabolism, published by NATURE PORTFOLIO, is a leading journal dedicated to advancing the field of metabolic research and its implications across various biological systems. Since its inception in 2019, this esteemed journal has rapidly established itself as a vital resource for researchers, professionals, and students alike, reflecting its prominence through a prestigious Q1 ranking in several key categories including Cell Biology, Endocrinology, Diabetes and Metabolism, Internal Medicine, and Physiology. With an impressive Scopus ranking, underscoring its impact in Medicine and Biochemistry disciplines, Nature Metabolism offers an exceptional platform for disseminating high-quality research that explores the intricate mechanisms of metabolism and its association with health and disease. Although currently not open access, it continues to gain visibility and appreciation within the scientific community, ensuring that groundbreaking findings reach interested audiences globally from its hub in Berlin, Germany. Whether you are an experienced researcher or an aspiring student, Nature Metabolism serves as an invaluable asset in navigating the complexities of metabolic science.